Dupixent 200 MG/1.14 ML syring 1.14ML
Ended Awarded Last action
- Contract number
- SPE2DR26FU134
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $67,496
Award facts
- Contract value 100% obligated
- $67,496.14 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $67,496.14 firm fixed price delivery order to AmerisourceBergen Drug Corp for Dupixent (dupilumab) 200 mg/1.14 mL syringes on November 24, 2025, with completion targeted for November 25, 2025. This non-set-aside contract represents a direct purchase under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The delivery order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen supplies critical medications and medical commodities to support military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. Dupixent is a specialty biologic medication used primarily for atopic dermatitis, asthma, and eosinophilic conditions, reflecting the company's established capability to procure and deliver high-value branded pharmaceutical products for federal medical programs. This delivery order exemplifies the flexible contracting approach under the broader pharmaceutical prime vendor framework, enabling the agency to meet military healthcare demand for specialized medications on an as-needed basis.
Quick answers
Who was awarded contract SPE2DR26FU134?
SPE2DR26FU134 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 24, 2025.
How much is contract SPE2DR26FU134 worth?
The government has obligated $67,496 on SPE2DR26FU134.
Is contract SPE2DR26FU134 an order under another contract?
Yes. SPE2DR26FU134 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FU134 competed?
The extent of competition for SPE2DR26FU134 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award